Company Filing History:
1 out of 3,923 
1 out of 13 
Years Active: 2022
Title: John Delmas Venable: Innovator in Antibody Molecules
Introduction
John Delmas Venable is a notable inventor based in San Diego, CA. He has made significant contributions to the field of biotechnology, particularly in the development of antibody molecules. His work focuses on innovative solutions for cancer treatment, prevention, and diagnosis.
Latest Patents
Venable holds a patent for "Antibody molecules to CD73 and uses thereof." This patent discloses antibody molecules that bind to CD73, which can be utilized in various therapeutic applications related to cancer. His innovative approach has the potential to impact cancer treatment significantly.
Career Highlights
Throughout his career, John Delmas Venable has worked with prominent companies in the biotechnology sector. He has been associated with Novartis AG and Surface Oncology, Inc., where he has contributed to advancing cancer therapies. His expertise in antibody development has positioned him as a key figure in his field.
Collaborations
Venable has collaborated with talented professionals, including Bianka Prinz and Jerry M. Thomas. These partnerships have fostered a collaborative environment that enhances innovation and research in antibody therapies.
Conclusion
John Delmas Venable's contributions to the field of biotechnology, particularly in antibody development, highlight his role as an innovator. His patent for antibody molecules to CD73 represents a significant advancement in cancer treatment. His work continues to inspire future innovations in the medical field.